Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
Abstract Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94173ec599664c7bb5c955481c28e941 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:94173ec599664c7bb5c955481c28e941 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:94173ec599664c7bb5c955481c28e9412021-12-02T11:40:22ZMethylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds10.1038/s41598-017-06067-52045-2322https://doaj.org/article/94173ec599664c7bb5c955481c28e9412017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06067-5https://doaj.org/toc/2045-2322Abstract Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes, MG increased oxidative stress and reduced myotube formation in C2C12 cells. RAGE (receptor for AGEs) expression was up-regulated and MYOD and myogenin (MYOG) expressions were concomitantly down-regulated in MG-treated cells. Interestingly, AGE levels were higher in plasma (~32 fold) and muscle (~26 fold) of diabetic mice than in control mice. RAGE knock-down (RAGEkd) reduced the expressions of MYOD and MYOG and myotube formation in C2C12 cells. In silico studies of interactions between curcumin or gingerol and myostatin (MSTN; an inhibitor of myogenesis) and their observed affinities for activin receptor type IIB (ACVRIIB) suggested curcumin and gingerol reduce the interaction between MSTN and ACVRIIB. The findings of this study suggest enhanced AGE production and subsequent RAGE-AGE interaction obstruct the muscle development program, and that curcumin and gingerol attenuate the effect of AGEs on myoblasts.Mohammad Hassan BaigArif Tasleem JanGulam RabbaniKhurshid AhmadJalaluddin M. AshrafTaeyeon KimHan Sol MinYong Ho LeeWon-Kyung ChoJin Yeul MaEun Ju LeeInho ChoiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mohammad Hassan Baig Arif Tasleem Jan Gulam Rabbani Khurshid Ahmad Jalaluddin M. Ashraf Taeyeon Kim Han Sol Min Yong Ho Lee Won-Kyung Cho Jin Yeul Ma Eun Ju Lee Inho Choi Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
description |
Abstract Methylglyoxal (MG) is a reactive dicarbonyl intermediate and a precursor of advanced glycation end products (AGEs). The authors investigated the role played by AGEs in muscle myopathy and the amelioration of its effects by curcumin and gingerol. In addition to producing phenotypical changes, MG increased oxidative stress and reduced myotube formation in C2C12 cells. RAGE (receptor for AGEs) expression was up-regulated and MYOD and myogenin (MYOG) expressions were concomitantly down-regulated in MG-treated cells. Interestingly, AGE levels were higher in plasma (~32 fold) and muscle (~26 fold) of diabetic mice than in control mice. RAGE knock-down (RAGEkd) reduced the expressions of MYOD and MYOG and myotube formation in C2C12 cells. In silico studies of interactions between curcumin or gingerol and myostatin (MSTN; an inhibitor of myogenesis) and their observed affinities for activin receptor type IIB (ACVRIIB) suggested curcumin and gingerol reduce the interaction between MSTN and ACVRIIB. The findings of this study suggest enhanced AGE production and subsequent RAGE-AGE interaction obstruct the muscle development program, and that curcumin and gingerol attenuate the effect of AGEs on myoblasts. |
format |
article |
author |
Mohammad Hassan Baig Arif Tasleem Jan Gulam Rabbani Khurshid Ahmad Jalaluddin M. Ashraf Taeyeon Kim Han Sol Min Yong Ho Lee Won-Kyung Cho Jin Yeul Ma Eun Ju Lee Inho Choi |
author_facet |
Mohammad Hassan Baig Arif Tasleem Jan Gulam Rabbani Khurshid Ahmad Jalaluddin M. Ashraf Taeyeon Kim Han Sol Min Yong Ho Lee Won-Kyung Cho Jin Yeul Ma Eun Ju Lee Inho Choi |
author_sort |
Mohammad Hassan Baig |
title |
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
title_short |
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
title_full |
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
title_fullStr |
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
title_full_unstemmed |
Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
title_sort |
methylglyoxal and advanced glycation end products: insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/94173ec599664c7bb5c955481c28e941 |
work_keys_str_mv |
AT mohammadhassanbaig methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT ariftasleemjan methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT gulamrabbani methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT khurshidahmad methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT jalaluddinmashraf methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT taeyeonkim methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT hansolmin methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT yongholee methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT wonkyungcho methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT jinyeulma methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT eunjulee methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds AT inhochoi methylglyoxalandadvancedglycationendproductsinsightoftheregulatorymachineryaffectingthemyogenicprogramandofitsmodulationbynaturalcompounds |
_version_ |
1718395659323703296 |